In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel
The world’s largest hornet, an invasive breed nicknamed the “murder hornet” for its dangerous sting and...
More than two months after Missouri residents voted to add abortion rights into their state constitution...
